1999
DOI: 10.1016/s1010-7940(99)00205-5
|View full text |Cite
|
Sign up to set email alerts
|

Bi-directional cavopulmonary shunt: is accessory pulsatile flow, good or bad?

Abstract: Despite two different initial palliative techniques the outcome was not significantly different. Accessory pulsatile blood flow appeared not to be a contra-indication for a completion Fontan procedure. Moreover, the data suggest that after accessory pulsatile flow can safely be performed, at late follow-up oxygen saturation is higher, while, significantly more and earlier completion of Fontan occurred. Age at bi-directional cavopulmonary shunt, basic left or right ventricular anatomy or previous palliative sur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
33
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(36 citation statements)
references
References 18 publications
3
33
0
Order By: Relevance
“…The ABG adds a component of pulsatility to the pulmonary blood flow, which could potentially improve pulmonary vascular development and exercise tolerance. 17,28 Our study does indicate that for the shunt size studied, nozzle/shunt designs having a b larger than 0.72 may be problematic as pulmonary artery pressures above 18 mmHg coupled with high PVR is a factor for surgery failure and possible death for stage 2 patients. 5 The VAD used in the open-loop MCS was not intended to be a consistent model of ventricle dynamics, nor would that be appropriate, but rather it provided a sufficiently realistic source of flow and pulsatility for the experimental system.…”
Section: Discussionmentioning
confidence: 87%
“…The ABG adds a component of pulsatility to the pulmonary blood flow, which could potentially improve pulmonary vascular development and exercise tolerance. 17,28 Our study does indicate that for the shunt size studied, nozzle/shunt designs having a b larger than 0.72 may be problematic as pulmonary artery pressures above 18 mmHg coupled with high PVR is a factor for surgery failure and possible death for stage 2 patients. 5 The VAD used in the open-loop MCS was not intended to be a consistent model of ventricle dynamics, nor would that be appropriate, but rather it provided a sufficiently realistic source of flow and pulsatility for the experimental system.…”
Section: Discussionmentioning
confidence: 87%
“…The reported mortality and morbidity rates in patients with accessory flow differ among institutions. Van deWal and colleagues 20 reported no influence on the survival rate in a study of 205 patients with an average age of 5.6 years; McElhinney and colleagues 21 reported higher, yet statistically insignificant, mortality in a study of 160 patients with an average age of 7.8 months; and Mainwaring and colleagues 22 reported higher mortality in study of 149 patients with an average age of 10 months. 23 Earlier completion of Fontan was reported in patients with accessory flow, and it has been argued that if hepatic-factor is important for the prevention of pulmonary arteriovenous malformation, then having accessory pulsatile flow might represent an advantage.…”
Section: Discussionmentioning
confidence: 96%
“…Adopting a systemically derived accessory pulmonary flow in the BDG circulation has been reported previously both clinically and investigationally, 2023 although typically not during the neonatal period. The reported mortality and morbidity rates in patients with accessory flow differ among institutions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Advocates of antegrade flow point out the higher oxygen saturations that result, as well as the theoretical effect of pulsatile flow on enhancing pulmonary artery growth [27,28]. Proponents of eliminating antegrade blood flow report a reduction in the extent and duration of postoperative pleural effusions as well as the difficulty in establishing how much antegrade blood flow is too much [29].…”
Section: Second Stage Palliationmentioning
confidence: 99%